Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
placebo intravenous infusion
DRUG
2 trials
Sponsors
Ocera Therapeutics, Inc.
, Wake Forest University Health Sciences
Conditions
Acute Episode of Overt Hepatic Encephalopathy
Hepatic Encephalopathy
Tobacco Use Disorder
Phase 1
The Effects of Sedatives on Tobacco Use Disorder
Completed
NCT03813121
Wake Forest University Health Sciences
Tobacco Use Disorder
Start: 2019-06-01
End: 2021-08-31
Updated: 2022-10-06
Phase 2
Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
Completed
NCT01966419
Ocera Therapeutics, Inc.
Acute Episode of Overt Hepatic Encephalopathy, Hepatic Encephalopathy
Start: 2014-01-07
End: 2016-12-29
Updated: 2021-09-16
Related Papers
Pharmacokinetics/pharmacodynamics of L‐ornithine phenylacetate in overt hepatic encephalopathy and the effect of plasma ammonia concentration reduction on clinical outcomes
Clinical and Translational Science
2022-03-03
19 citations
Efficacy and Safety of Ornithine Phenylacetate for Treating Overt Hepatic Encephalopathy in a Randomized Trial
Clinical Gastroenterology and Hepatology
2020-10-16
64 citations